Biography of Mikael Dolsten
Last update: February 26, 2024Career
Mikael was President and Head of R&D at Wyeth Pharmaceuticals, and Private Equity Partner at OrbiMed Advisors. Mikael Dolsten joined Pfizer in 2009. Mikael served as Global President, Research and Development at Pfizer.
Mikael Dolsten is currently- President at Pfizer R&D - View - Pfizer R&D org chart
- Chief Scientific Officer and President, Research & Development at Pfizer - View - Pfizer org chart
- Director at Agilent Technologies - View - Agilent Technologies org chart
- Director at Vimian Group - View - Vimian Group org chart
Create your alert
to follow the career of Mikael Dolsten.
Education
Mikael Dolsten has a Doctor of Medicine from Lund University.
They have also studied at Lund University :
Find more alumni from Lund University
More about Mikael Dolsten
Selected links
Do you need to know more about Mikael Dolsten? More results.
Participate
Social media
- Mikael Dolsten on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Mikael Dolsten
The colleagues of Mikael Dolsten
Company Colleagues
- At Pfizer R&D, Mikael Dolsten has 7 colleagues including Peter McGuigan (Finance), Uwe Schoenbeck (Science)…
- At Pfizer, Mikael Dolsten has 353 colleagues including Albert Bourla (CEO & Chairman), Susan Desmond-Hellmann (Director)…
- At Agilent Technologies, Mikael Dolsten has 41 colleagues including Padraig McDonnell (CEO), Mala Anand (Director)…
- At Vimian Group, Mikael Dolsten has 15 colleagues including Patrik Eriksson (CEO), Theodor Bonnier (Director)…
Industry Colleagues
- In the Biotechnology industry, Mikael Dolsten has 30,296 colleagues in 2,285 companies located in 40 countries. 14,308 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Mikael Dolsten.
Get in Touch
and ask for Mikael Dolsten.
